Omega Pharma NV

Engages in the development and sale of prescription-free health and personal care products to pharmacies.

Launch date

1987

Market cap

Enterprise valuation

AUD7.0b (Public information from Mar 2015)

Nazareth East Flanders (HQ)

Date	Investors	Amount	Round
Jan 2012	Waterland Private Equity	$848m Valuation: $848m	Buyout
Mar 2015	Perrigo	$4.5b Valuation: $4.5b	Acquisition
Total Funding		-

ACQUISITION by Omega Pharma NV Dec 2001

Recent News about Omega Pharma NV